Diagnostics Company Named In Antibodies Test Accuracy Stock-Drop Suit
NEW YORK — A point-of-care diagnostics company and two of its senior executives misrepresented the accuracy of its antibody test used to determine current or past exposure to COVID-19 in violation...To view the full article, register now.
Already a subscriber? Click here to view full article